Home Cart 0 Sign in  

[ CAS No. 73620-18-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 73620-18-5
Chemical Structure| 73620-18-5
Structure of 73620-18-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 73620-18-5 ]

Related Doc. of [ 73620-18-5 ]

Alternatived Products of [ 73620-18-5 ]

Product Details of [ 73620-18-5 ]

CAS No. :73620-18-5 MDL No. :MFCD00463122
Formula : C10H10O4 Boiling Point : -
Linear Structure Formula :- InChI Key :TVJPCDPSAWVMHA-UHFFFAOYSA-N
M.W : 194.18 Pubchem ID :758214
Synonyms :

Calculated chemistry of [ 73620-18-5 ]

Physicochemical Properties

Num. heavy atoms : 14
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.2
Num. rotatable bonds : 5
Num. H-bond acceptors : 4.0
Num. H-bond donors : 0.0
Molar Refractivity : 49.22
TPSA : 52.6 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.87 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.88
Log Po/w (XLOGP3) : 0.87
Log Po/w (WLOGP) : 1.05
Log Po/w (MLOGP) : 0.74
Log Po/w (SILICOS-IT) : 1.77
Consensus Log Po/w : 1.26

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.58
Solubility : 5.12 mg/ml ; 0.0264 mol/l
Class : Very soluble
Log S (Ali) : -1.56
Solubility : 5.37 mg/ml ; 0.0276 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.57
Solubility : 0.521 mg/ml ; 0.00269 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.62

Safety of [ 73620-18-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 73620-18-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 73620-18-5 ]
  • Downstream synthetic route of [ 73620-18-5 ]

[ 73620-18-5 ] Synthesis Path-Upstream   1~8

  • 1
  • [ 73620-18-5 ]
  • [ 22042-71-3 ]
Reference: [1] Organic Letters, 2004, vol. 6, # 12, p. 2019 - 2022
[2] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 8, p. 2123 - 2125
[3] Journal of Organic Chemistry, 1996, vol. 61, # 11, p. 3623 - 3634
[4] European Journal of Medicinal Chemistry, 2010, vol. 45, # 2, p. 639 - 646
  • 2
  • [ 123-08-0 ]
  • [ 96-32-2 ]
  • [ 73620-18-5 ]
YieldReaction ConditionsOperation in experiment
82% With potassium carbonate In acetone at 20℃; for 3.5 h; Methyl 2-(4-formylphenoxy)acetate. To a solution of 4-hydroxybenzaldehyde (3.0 g, 25 mmol) in acetone (61.4 mL), K2C03 (5.43 g, 39.3 mmol) was added and the mixture was stilTed vigorously. Methyibromoacetate (2.8 mL, 29 mmol) was added and the mixture was stirred for 3.5 hrs at room temperature. The reaction mixture was concentrated down under reduced pressure then washed with 11O and extracted with EtOAc. The organic layer was separated, dried over Na2SO4, filtered, and concentrated to give a colorless oil that solidified under vacuum in 82 percent isolated yield. ‘H NMR (400 MHz, CDC13) 3 9.87 (s, 111),7.82 (d, J = 8.8 Hz, 211), 6.98 (d, J = 8.7 Hz, 211), 4.70 (s, 211), 3.79 (s, 3H). ESI-MS (mlz):195.1 [M+Hjt
82% With potassium carbonate In acetone at 20℃; for 3.5 h; To a solution of 4-hydroxybenzaldehyde (3.0 g, 25 mmol) in acetone (61.4 mL), K2CO3 (5.43 g, 39.3 mmol) was added and the mixture was stirred vigorously. Methylbromoacetate (2.8 mL, 29 mmol) was added and the mixture was stirred for 3.5 hrs at room temperature. The reaction mixture was concentrated down under reduced pressure then washed with 0 and extracted with EtOAc. The organic layer was separated, dried over Na2S04, filtered, and concentrated to give a colorless oil that solidified under vacuum in 82 percent isolated yield. H NMR (400 MHz, CDC13) δ 9.87 (s, 1H),
82% With potassium carbonate In acetone at 20℃; for 3.5 h; To a solution of 4-hydroxybenzaldehyde (3.0 g, 25 mmol) in acetone (61.4 mL), K2CO3 (5.43 g, 39.3 mmol) was added and the mixture was stirred vigorously. Methylbromoacetate (2.8 mL, 29 mmol) was added and the mixture was stirred for 3.5 hrs at room temperature. The reaction mixture was concentrated down under reduced pressure then washed with H2O and extracted with EtOAc. The organic layer was separated, dried over Na2SO4, filtered, and concentrated to give a colorless oil that solidified under vacuum in 82 percent isolated yield. 1H NMR (400 MHz, CDCl3) δ 9.87 (s, 1H), 7.82 (d, J = 8.8 Hz, 2H), 6.98 (d, J = 8.7 Hz, 2H), 4.70 (s, 2H), 3.79 (s, 3H). ESI-MS (m/z): 195.1 [M+H]+.
Reference: [1] Organic Letters, 2011, vol. 13, # 20, p. 5656 - 5659
[2] Organic Letters, 2004, vol. 6, # 12, p. 2019 - 2022
[3] Chemistry - A European Journal, 2008, vol. 14, # 19, p. 5812 - 5819
[4] Patent: WO2015/65716, 2015, A1, . Location in patent: Paragraph 00490
[5] Patent: WO2016/144958, 2016, A1, . Location in patent: Paragraph 00296
[6] Patent: WO2018/17582, 2018, A1, . Location in patent: Paragraph 00285
[7] Journal of Chemical Research, Miniprint, 1987, # 12, p. 3144 - 3177
[8] Bioorganic and Medicinal Chemistry Letters, 2001, vol. 11, # 19, p. 2589 - 2592
[9] Journal of Organic Chemistry, 1996, vol. 61, # 11, p. 3623 - 3634
[10] Patent: US6469167, 2002, B1,
[11] Patent: WO2005/11685, 2005, A1, . Location in patent: Page/Page column 43-44
[12] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 9, p. 2601 - 2605
[13] CrystEngComm, 2010, vol. 12, # 12, p. 4095 - 4100
[14] Organic Process Research and Development, 2012, vol. 16, # 4, p. 586 - 594
[15] Patent: CN103739540, 2016, B, . Location in patent: Paragraph 0100-0103
[16] Chemistry - A European Journal, 2018, vol. 24, # 49, p. 12950 - 12960
  • 3
  • [ 123-08-0 ]
  • [ 96-34-4 ]
  • [ 73620-18-5 ]
YieldReaction ConditionsOperation in experiment
66.1% With potassium carbonate; sodium iodide In acetone for 12 h; Heating / reflux Example 68
(4-Formylphenoxy)acetic Acid Methyl Ester (68)
To a mixture of 4-hydroxy benzaldehyde (200 grams, 1.64 mol), anhydrous K2CO3 (600 grams, 4.34 mol) and sodium iodide (20 grams, 133 mol) in anhydrous acetone (2500 mL) was added methyl chloro acetate (223 grams, 2.055 mol) and refluxed for 12 hours.
Acetone was distilled and water (1800 mL) was added.
Crude 68 was extracted in to chloroform, dried over Na2SO4, distilled and purified by column chromatography on silica gel using hexane as eluant to give pure 68 (210 grams, 66.1percent) as a white powder.
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 8, p. 2123 - 2125
[2] Patent: US2009/170927, 2009, A1, . Location in patent: Page/Page column 28
[3] Patent: US6469167, 2002, B1,
[4] European Journal of Medicinal Chemistry, 2010, vol. 45, # 2, p. 639 - 646
[5] Steroids, 2012, vol. 77, # 5, p. 552 - 557
[6] Bioorganic Chemistry, 2016, vol. 65, p. 26 - 37
  • 4
  • [ 96-32-2 ]
  • [ 73620-18-5 ]
Reference: [1] Patent: WO2005/12280, 2005, A1, . Location in patent: Page/Page column 48-49
  • 5
  • [ 96-35-5 ]
  • [ 123-08-0 ]
  • [ 73620-18-5 ]
YieldReaction ConditionsOperation in experiment
67% With triphenylphosphine In tetrahydrofuran; diethylazodicarboxylate EXAMPLE 44
Methyl 2-(4-formylphenoxy)ethanoate
A solution of 4-hydroxy benzaldehyde, (1.22 g, 0.01 m), methyl glycolate (0.97 g, 0.01 m), and triphenylphosphine, (3.93 g, 0.015 m), in dry tetrahydrofuran, (50 ml) was stirred with cooling in ice and diethylazodicarboxylate, (2.61 g, 0.015 m), added dropwise.
The solution was stirred at room temperature for 0.5 hours, then evaporated in vacuo to dryness.
Column chromatography of the residue on silica gel eluding with chloroform yielded 1.30 g (67percent) of the title compound as an oil which crystallized on standing, mp 39°-41° C., νmax (mull) 1750, 1680, 1595, 1575, 1505 cm-1.
Reference: [1] Patent: US4713486, 1987, A,
  • 6
  • [ 22042-71-3 ]
  • [ 18107-18-1 ]
  • [ 73620-18-5 ]
Reference: [1] Patent: US2006/281751, 2006, A1, . Location in patent: Page/Page column 25
  • 7
  • [ 67-56-1 ]
  • [ 22042-71-3 ]
  • [ 73620-18-5 ]
Reference: [1] Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 1996, vol. 35, # 5, p. 409 - 412
  • 8
  • [ 186581-53-3 ]
  • [ 22042-71-3 ]
  • [ 73620-18-5 ]
Reference: [1] Russian Journal of Organic Chemistry, 2008, vol. 44, # 5, p. 657 - 670
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 73620-18-5 ]

Aryls

Chemical Structure| 22042-71-3

[ 22042-71-3 ]

2-(4-Formylphenoxy)acetic acid

Similarity: 0.98

Chemical Structure| 40359-34-0

[ 40359-34-0 ]

Methyl 2-(2-formylphenoxy)acetate

Similarity: 0.96

Chemical Structure| 51264-76-7

[ 51264-76-7 ]

2-(2-Ethoxy-4-formylphenoxy)acetic acid

Similarity: 0.94

Chemical Structure| 22042-73-5

[ 22042-73-5 ]

4-(2-Hydroxyethoxy)benzaldehyde

Similarity: 0.87

Chemical Structure| 6322-83-4

[ 6322-83-4 ]

2-(4-Benzoylphenoxy)acetic acid

Similarity: 0.86

Aldehydes

Chemical Structure| 22042-71-3

[ 22042-71-3 ]

2-(4-Formylphenoxy)acetic acid

Similarity: 0.98

Chemical Structure| 40359-34-0

[ 40359-34-0 ]

Methyl 2-(2-formylphenoxy)acetate

Similarity: 0.96

Chemical Structure| 51264-76-7

[ 51264-76-7 ]

2-(2-Ethoxy-4-formylphenoxy)acetic acid

Similarity: 0.94

Chemical Structure| 22042-73-5

[ 22042-73-5 ]

4-(2-Hydroxyethoxy)benzaldehyde

Similarity: 0.87

Chemical Structure| 72207-94-4

[ 72207-94-4 ]

2-Ethoxy-4-formylphenyl acetate

Similarity: 0.86

Ethers

Chemical Structure| 22042-71-3

[ 22042-71-3 ]

2-(4-Formylphenoxy)acetic acid

Similarity: 0.98

Chemical Structure| 40359-34-0

[ 40359-34-0 ]

Methyl 2-(2-formylphenoxy)acetate

Similarity: 0.96

Chemical Structure| 51264-76-7

[ 51264-76-7 ]

2-(2-Ethoxy-4-formylphenoxy)acetic acid

Similarity: 0.94

Chemical Structure| 22042-73-5

[ 22042-73-5 ]

4-(2-Hydroxyethoxy)benzaldehyde

Similarity: 0.87

Chemical Structure| 6322-83-4

[ 6322-83-4 ]

2-(4-Benzoylphenoxy)acetic acid

Similarity: 0.86

Esters

Chemical Structure| 40359-34-0

[ 40359-34-0 ]

Methyl 2-(2-formylphenoxy)acetate

Similarity: 0.96

Chemical Structure| 72207-94-4

[ 72207-94-4 ]

2-Ethoxy-4-formylphenyl acetate

Similarity: 0.86

Chemical Structure| 88530-52-3

[ 88530-52-3 ]

Methyl 2-(4-(tert-butyl)phenoxy)acetate

Similarity: 0.84

Chemical Structure| 881-68-5

[ 881-68-5 ]

4-Formyl-2-methoxyphenyl acetate

Similarity: 0.82

Chemical Structure| 56441-97-5

[ 56441-97-5 ]

Methyl 4-(benzyloxy)-3-methoxybenzoate

Similarity: 0.81